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Background and Aims: Cancer is increasingly common among persons living with HIV (PLWH). A 
higher incidence of liver and non-liver cancers among persons with chronic hepatitis C infection has been 
documented. This study compared the incidence, characteristic and the time trends in PLWH with HCV-
coinfection (HIV/HCV) and without (HIV) who develop a tumor. 
 
Methods: Retrospective cohort study including all cancers in PLWH in care, in a hospital of the Norwest 
of Spain (period 1993-2014).Epidemiological, demographic, clinical and immuno-virological data were 
recorded. Cancers were classified in two groups: AIDS defining cancer (ADC) and non AIDS-defining 
cancer (NADC). Patients were followed until last regular clinical visit, death or lost of follow-up. 
Incidence of malignancies was evaluated and a comparative analysis between HIV and HIV/HCV was 
performed. 
 
 
Results: A total of 2318 PLWH were included, of which 185 (117 HIV and 68 HIV/HCV) developed at 
least one tumor. Patients who developed a tumor were mostly males (81%), with a mean age of44 ± 11 
years old, 67% C-CDC, 60% were on antiretroviral therapy and37% of HIV/HCV were cirrothic; without 
differences between HIV and HIV/HCV. Cancer incidence increased from 1993 to 2014, more in 
HIV/HCV than in HIV (see Figure).Non-Hodgkin lymphoma (32.7%), Kaposi’s sarcoma (25.7%) and 
lung cancers (16.8%) were the most frequent cancers in HIV; while hepatocarcinoma (27.1%), lung 
cancers (23.7%) and Non-Hodgkin lymphoma (18.6%) were in HIV/HCV. All hepatocarcinomas (17 
cases) were diagnosed in HIV/HCV and after 2003.The incidence rate (tumors per 1000 person-year) was 
4.5 for ADC in HIV and 1.3 in HIV/HCV; for NADC was 3.8 in HIV and 4.2 in HIV/HCV. The timing of 
cancer incidence after HIV diagnosis was 1 year for ADC in HIV and 10 years in HIV/HCV; for NADC it 
was 7 years in HIV and 14 years in HIV/HCV. One-year mortality was 44.4% in HIV and52.9% in 
HIV/HCV (p = 0.3). 
 
Conclusions: The current incidence of cancer is higher in HIV/HCV than in HIV, especially NADC but 
not only due to the hepatocarcinoma. HCV seems to add a risk of cancer in PLWH, likely due to an 
increase inflammation and the extrahepatic manifestations of HCV infection. The impact of preventive 
actions and HCV eradication should be evaluated. 
 
 
 
